Skip to main content

Closed

FDMT: 4D Molecular Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-203.5%

ROIC-37.8%

Financially safe

Stretched

Debt / equity0.05×

Interest coverage0.0×

Current ratio9.34×

4D Molecular Therapeutics, Inc.

FDMTNASDAQ Global Select·USD·Closed

4D Molecular Therapeutics, Inc.

FDMTNASDAQ·USD·Closed

$10.18

+1.09%

$10.18

+$0.11 (1.09%)

52W Range

58thpctl

Volume

0.81×avg

Mkt Cap

532.17MUSD

P/E

-3.8TTM

Div Yield

–ann

52W Range

58thpctl

Volume

0.81×avg

Market Cap

532.17MUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings